VRAX

Virax Biolabs Group Limited - Ordinary Shares (VRAX)

About Virax Biolabs Group Limited - Ordinary Shares (VRAX)

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Details

Daily high
$0.33
Daily low
$0.31
Price at open
$0.31
52 Week High
$2.33
52 Week Low
$0.30
Market cap
2.3M
Dividend yield
0.00%
Volume
192,015
Avg. volume
520,962
P/E ratio
-.24

Virax Biolabs Group Limited - Ordinary Shares News

Details

Daily high
$0.33
Daily low
$0.31
Price at open
$0.31
52 Week High
$2.33
52 Week Low
$0.30
Market cap
2.3M
Dividend yield
0.00%
Volume
192,015
Avg. volume
520,962
P/E ratio
-.24